Skip Navigation

  1. About Us
    1. Overview
    2. History
    3. Recognition
    4. Offices
  2. Our Practice
    1. Practice Areas
      1. Patents, Utility Models, and Industrial Designs
      2. Trademarks
      3. Copyrights
      4. Corporate, Commercial and Business Law
      5. IP Litigation, Alternative Dispute Resolution
      6. Regulatory Law
      7. Licensing, Tech Transfer & Franchising
      8. Anti-Piracy, Anti-Counterfeiting & Enforcement
    2. Industry Groups
      1. Media, Sports & Entertainment Law Group
      2. Life Science & Pharmaceutical Law Group
  3. Our People
    1. Partners
      1. Sergio L. Olivares, Sr. † (1931-2010)
      2. Sergio L. Olivares, Jr.
      3. Luis C. Schmidt
      4. Cesar Ramos, Jr.
      5. Antonio Belaunzaran
      6. Gustavo A. Alcocer
      7. Jose Ignacio De Santiago
      8. Alejandro Luna
      9. Alonso Camargo
      10. Daniel Sanchez
    2. Associates (A - M)
      1. Osvaldo Amaral
      2. Armando Arenas
      3. Sofía Arroyo
      4. Guillermo Ballesteros
      5. Varinia Calleros
      6. Abraham Diaz
      7. Georgina Flores
      8. Pedro Herrera
      9. Carlos Maya
    3. Associates (N - Z)
      1. Mauricio Narváez
      2. Víctor Ramírez
      3. Sergio Rangel
      4. Maria del Carmen Sada
      5. Juan Luis Serrano
      6. Guillermo Treviño
      7. Carlos Woodworth
    4. All Attorneys / Engineers
    5. Firm Administration
  4. Knowledge & Resources
    1. Articles
      1. Trademark Law Articles
        1. Use requirements
        2. Approach to composite marks changed, again
        3. Life Sciences Handbook 2011 - Country Q&A
        4. Mexico should accept secondary meaning
        5. Getting the Deal Through - Trademarks 2011
        6. Pharmaceutical Trademarks 2010/2011 - A Global Guide
        7. No legal basis for banning names derived from INNs
        8. How Latin America tackles cutting-edge IP issues
        9. Specialised IP court corrects IMPI
        10. Protecting trade dress
        11. 43 more items...
      2. Patent Law Articles
        1. Mexico issues regulations to approve biologic drugs
        2. Latin America Roundtable
        3. New regulations pending
        4. The International Comparative Guide
        5. Marketing authorization for pharmaceutical
        6. Approval of follow-on biologics in Mexico
        7. Mexican Linkage Gazette April 2011
        8. Patent Prosecution Highway in Mexico
        9. Life Sciences Handbook 2011 - Country Q&A
        10. Data Package Exclusivity (DPE)
        11. 35 more items...
      3. Copyright Law Articles
        1. Advertising in social media networks
        2. Technology challenges digital rights
        3. Exceptions to copyright protection and the permitted uses of copyright works in the hi-tech and digital sectors
        4. Derechos sobre producción audiovisual
        5. How Latin America tackles cutting-edge IP issues
        6. Copyright Litigation 2010
        7. Legislation and enforcement - Copyrights 2010
        8. Valuing folklore
        9. Protecting novel ideas
        10. Mexico's fair use balancing act
        11. 100 more items...
      4. Corporate Law Articles
        1. Mexico issues Personal Data Protection Rules
        2. How data affects innovation
        3. A practical cross-border
        4. New registry for security interests
        5. The International Comparative Legal Guide to: Merger Control 2011
        6. The International Comparative Legal Guide to: Merger Control 2010
        7. Due diligence issues to consider in M&A
        8. Income expectations in licensing
        9. The reasons for valuation
        10. Amendments proposed to franchise regulation
      5. IP Litigation, ADR Articles
        1. Scope of new specialised courts widened
        2. Reform of preliminary injunctions
        3. Mexican Patent Office excludes Formulation Patents from Linkage Gazette
        4. Mexico gets ready to approve biocomparable drugs
        5. Mexico's hotel for the stars highlights power in the name
        6. Supreme Court upholds the worth of formulation patents
        7. Getting the Deal Through - Patents 2010
        8. Getting the Deal Through Trademarks 2010
        9. Trademark enforcement
        10. Venues for appealing IMPI decisions
        11. 15 more items...
      6. Regulatory Law Articles
        1. Amendments to the Federal Law for Consumer Protection
        2. Mexico issues Personal Data Protection Rules
        3. New Regulations Pending
        4. Marketing authorization for pharmaceutical products to foreign applicants
        5. Data Package Exclusivity (DPE)
        6. Supreme Court upholds the worth of formulation patents
        7. Pharmaceutical trademarks
        8. Framework for biotherapeutic products established
        9. Pharmaceutical Advertising 2009
        10. New Regulations for pharma industry
        11. 3 more items...
      7. Licensing, Tech Transfer Articles
        1. Creating a secure franchise system
      8. Anti-Piracy, Anti-Counterfeiting Articles
        1. New register against counterfeits
        2. Beat the counterfeiters in Mexico
        3. Battling counterfeits through Customs
        4. Getting the Deal Through Trademarks 2010
        5. Enforcing plant variety rights in Mexico
        6. Pharmaceutical Trademarks 2009
        7. Internet Issues
        8. Anti-counterfeiting 2009
        9. Vegetal variety rights enforced
        10. New Customs rules lead to seizures
        11. 3 more items...
      9. Media, Sports & Entertainment Focused Articles
        1. Whither Rental Rights?
        2. Improved protection for personalities
      10. Life Sciences Focused Articles
        1. Latin America Roundtable
        2. New regulations pending
        3. The International Comparative
        4. Approval of follow-on biologics in Mexico
        5. Global Pharmaceutical Linkage Regulations:
        6. Life Sciences Handbook 2011 - Country Q&A
        7. Supreme Court upholds the worth of formulation patents
        8. Repercussions expected on medicine advertising campaign in Mexico
        9. Framework for biotherapeutic products established
        10. Pharmaceutical Trademarks 2009
        11. 1 more item...
    2. Webinar Archive
      1. Webinar - Changes to Mexican Patent and Healthcare Laws for Life Sciences
      2. Webinar - Digital Rights Issues in Copyright Law
      3. Webinar - Data Package Exclusivity Rights in Latin America
    3. Recognition
    4. News
      1. Presumed Guilty - How can a law firm help win an Emmy?
      2. New rules came in force to speed timeframes in administrative appeal proceedings
      3. Recent reforms to the Mexican Industrial Property Law dealing with trademark priority rights
      4. Olivares & Cia. ranking
      5. Data Package Exclusivity (DPE)
      6. Mr. Sergio Olivares Sr's Passing
      7. Pharma Linkage Regulations Supreme Court Decision
      8. Managing IP magazine has recognized Olivares & Cia. as the leading firm for patent work in Mexico
      9. Mexican Congress amends the Patent Law
      10. Implementation of the Federal Law for the Protection of Personal Data in Possession of Private Entities
  5. Events
  6. Offices
  7. Contact Us
  8. Quick guide to Mexico’s regulatory system
    1. Patent regulatory overview
    2. Trademark regulatory overview
    3. Copyright regulatory overview
    4. Corporate & Commercial Regulatory overview

Home » Knowledge & Resources » Articles » Copyright Law Articles » The changing face of copyright

The changing face of copyright

By Luis C. Schmidt, Partner
Copyright World Issue # 190, May 2009

"New technologies allow everybody to be their own copier, publisher or public communicator"

Copyright law is a field of law that has been designed with the purpose of connecting interests of different kinds, frequently in conflict. In the first place stands the author of the works. Copyright would not exist without a physical creator of the work-of-authorship. No less important is the publisher, who utilizes media capable of disseminating the works, to make them accessible to everybody. In a blurry in-between position stands society, the receiver of works and the ultimate beneficiary that authors and publishers seek.
The Statute of Anne, a legacy to both the "copyright "and the "author's right" authors’ and publishers’ rights. Society would encourage authors to create and publishers to disseminate by conferring them exclusive rights to publish the works, in exchange of making culture and learning available to all. The rights to publish would necessarily return to society after the authors and their heirs, as well as the publishers, had enjoyed them for sufficient time.
The Statute of Anne took an antimonopoly orientation since censorship and monopoly had played against the rightful interests of society, in terms of how difficult it was having access to works. The Statute of Anne introduced trade-regulation and public domain worlds, was first to recognize the rights of society within creation and publication of works. Before the Statute of Anne was approved, society's rights and interest had been vastly neglected.
By conferring royal charter and privileges to the Stationers' Company, Mary Tudor was able to take control of the press (invented by Johan Gutenberg and brought to England by William Caxton) and impose monopoly and censorship rules to everything that was published.
Stationers' Copyright was the first form of protection for works, but it worked for the sole benefit of the crown and the Stationers’ Company.
The Statute of Anne was a major expression of improved protection, inasmuch as it viewed society's need for learning as the central reason to grant as fundamental principles, ensuring availability of works to the people and a better balance among traditional forces and the newly-recognized position of society. In the end, statutory control of monopoly and censorship as well as of perpetuity of rights are the first examples of success and achievement that society has gained and that have contributed to the confection of a copyright systemized law.
It is clear that society has played a crucial role in building up the framework of modem copyright law. It sometimes has helped as well to fill gaps or reduce tensions that originate from non-conciliatory differences between copyright and author's rights systems — the systems emphasise authorship or publishing as vehicles of creativeness and learning and that are difficult to reconcile and even more to harmonise — or solving disputes between authors and publishers that result from global electronic or tangible forms of trade of copyright products.
New technologies allow everybody to be their own copier, publisher or public communicator. The foregoing has already transformed the way that entertainment and cultural business has been made for quite sometime. Traditional authors and publishers may have simply ignored this fact, and may have forgotten that users demand prompt and non-discriminatory access to works, without restrictions of any kind — including territorial restrictions — and for a reasonable fee. They are perhaps busy fighting their own battles, without noticing that society has challenged existing copyright structures, pointing out business, economic and legal reform needs.
This time it has been different from the times of the Statute of Anne, as technology has de facto empowered society and has place it in a position above authors and publishers.